- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06593275
Pain Perception in Protection of the Palatal Donor Area After Harvesting a Free Gingival Graft Using Flowable Resin Versus a Self-adhesive Dressing
October 7, 2024 updated by: Antonio Lanata Flores, Universidad de Especialidades Espiritu Santo
The use of a connective tissue graft harvested from the palate is currently one of the most effective and predictable alternatives for the correction of periodontal and peri-implant defects, but the discomfort generated in the palate is sometimes greater than mucogingival surgery.
For this reason, we found the need to use different materials for palatal protection.
In one group we will use light-cured fluid resin compared to another group a self-adhesive dressing to check which of these materials provides less postoperative pain generated by the harvest of a free gingival graft.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
The postoperative pain generated by the harvest of a free gingival graft for the correction of periodontal or peri-implant defects, it's greater when it is not adequately protected and until the reepithelialization of the area is complete.
For this reason, it was decided to use two materials to compare the effectiveness in reducing postoperative pain in grafts larger than 15 mm.
A control group will be treated with a hemostatic collagen sponge and photocured fluid resin, adhered to the palatal surfaces of the neighboring teeth using an adhesive protocol and X-shaped sutures.
Another experimental group will be treated with a hemostatic sponge and placement of a self-adhesive dressing stabilized by X-shaped sutures to ensure its permanence in the mouth.
The participants will fill out a daily visual analog scale form for 14 days until the removal of the materials.
Finally, the results will be tabulated and compared to provide a conclusion of our study.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guayas
-
Samborondon, Guayas, Ecuador, 09-01-952
- Universidad de Especialidades Espiritu Santo
-
Contact:
- Antonio G Lanata, 5 level
- Phone Number: +593983820084
- Email: alanata@uees.edu.ec
-
Contact:
- Christian G Garcia, 3 level
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients over 18 years of age
- Patients with plaque control less than 20%
- Patients with bleeding on probing less than 10%
- Patients in need of periodontal or peri-implant surgery in the upper or lower jaw
- Not having previous surgeries in the donor area
Exclusion Criteria:
- Pregnant or breastfeeding patients
- Patients with lesions in the palate
- Patients who use prostheses that cover the palate
- Patients with active periodontal disease
- Patients who smoke
- Patients with systemic diseases
- Torus palatinus
- Patients with a history of chemotherapy and radiotherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control group
This group is defined by the use of a collagen hemostatic sponge and photocured fluid resin for the protection of the palatal donor area by means of an adhesive protocol to the palatal surfaces of the neighboring teeth and fixed with X-suture to improve its stability in the area.
A visual analog scale examination will be performed to assess the postoperative pain generated in the palate from day 1 to 14 and ending with the removal of this protection.
|
Use of fluid resin for protection of the palatal donor area to assess postoperative pain generated during14 days
|
|
Experimental: Experimental group
This group is defined by the use of a collagen hemostatic sponge and a self-adhesive dressing for the protection of the palatal donor area and fixed with an X-shaped suture to improve its stability in the area.
A visual analog scale examination will be performed to evaluate the postoperative pain generated in the palate from day 1 to 14 and ending with the removal of this protection.
|
Use of a self-adhesive dressing for protection of the palatal donor area to evaluate postoperative pain generated for 14 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain perception in the palate
Time Frame: Participants will fill out forms from day 1 after surgery until day 14
|
The harvesting of a connective tissue graft from the palate is the gold standard for periodontal and peri-implant surgery, in which the patient reports greater discomfort in this area if it is not properly protected.
From this point of view, randomized patients who will receive protection with fluid resin or self-adhesive dressing will be required to fill out a visual analog scale form in which 0 is the minimum pain presented and 10 the maximum pain.
The results will be tabulated to make a comparison between both techniques and to verify which one presented the least postoperative pain.
|
Participants will fill out forms from day 1 after surgery until day 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 30, 2024
Primary Completion (Estimated)
December 15, 2024
Study Completion (Estimated)
December 15, 2029
Study Registration Dates
First Submitted
September 9, 2024
First Submitted That Met QC Criteria
September 9, 2024
First Posted (Actual)
September 19, 2024
Study Record Updates
Last Update Posted (Actual)
October 10, 2024
Last Update Submitted That Met QC Criteria
October 7, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2024-ODONT-002B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perception of Pain
-
Cairo UniversityNot yet recruitingPain Perception of the New Device
-
King Abdulaziz UniversityCompletedPain Perception of the New DeviceSaudi Arabia
-
Medical University of ViennaRecruitingTransgender Persons | Pain Threshold | Sex Hormones | Perception of PainAustria
-
King Abdulaziz UniversityCompletedPain Perception of the New Device | The Pain Related Behavior | The Effectiveness of AnesthesiaSaudi Arabia
-
Shatha Musaad AlharthiNot yet recruiting
-
Mouetaz KheirallahActive, not recruiting
-
The University of QueenslandCompleted
-
University of CincinnatiWithdrawnPerception of ImagingUnited States
-
AstraZenecaCompletedPerception of Physicians & Patients of AMD
-
Abant Izzet Baysal UniversityCompletedPerception of Caring Behaviors | Quality of Nursing CareTurkey (Türkiye)
Clinical Trials on Protection of the palatal donor area with flowable resin
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingSoft Tissue AtrophyRussian Federation
-
G. d'Annunzio UniversityCompleted
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingEnteral Feeding IntoleranceFrance
-
Silesian Centre for Heart DiseasesMedical University of Silesia; Biostat Sp. z o.o.; Leszek Giec Upper-Silesian...RecruitingDepression | Cognitive Impairment | Atrial Fibrillation | Silent StrokePoland
-
Alexandria UniversityActive, not recruitingAnesthesia, LocalEgypt
-
Qassim UniversityRecruiting
-
Nanfang Hospital, Southern Medical UniversityRecruitingAndrogenetic Alopecia (AGA)China
-
Assistance Publique - Hôpitaux de ParisImagine Institute; Axonal-Biostatem; CERBA laboratory; SATT; SNC Graft Versus Host...RecruitingAcute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Lymphoma in Remission | Non-progressive Myeloproliferative Syndrome | Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts | Acute Leukemia Biphenotypic in RemissionFrance, Germany, Belgium
-
Affiliated Hospital of Nantong UniversityTongzhou District Hospital; Haimen People's Hospital; Dongtai People's Hospital; Qidong City People's Hospital and other collaboratorsRecruitingGastric Cancer Stage IChina
-
Fundación de investigación HMRecruiting